Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.

Name: Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.
Author: Mora, Jaume

Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events. — المؤلف: Mora, Jaume — Cancer reports (Hoboken, N.J.) 20230126

المؤلف: Mora, Jaume
النشر: Cancer reports (Hoboken, N.J.) 20230126
الوصف: e1627 p.
الموضوعات: United States؛ Humans؛ Child؛ Granulocyte-Macrophage Colony-Stimulating Factor؛ Outpatients؛ Bronchial Spasm؛ Neuroblastoma؛ Pain